Showing 3311-3320 of 5773 results for "".
- Bausch + Lomb Launches Lumify Eye Illuminations in the UShttps://modernod.com/news/bausch-lomb-launches-lumify-eye-illuminations-in-the-united-states/2481846/Bausch + Lomb announced the US launch of Lumify Eye Illuminations, a new line of hypoallergenic specialty eye care products developed to cleanse, nourish and brighten the sensitive eye area. “Many products contain chemicals or preservatives that can irritate the del
- Pixium Vision Complete Reverse Stock Splithttps://modernod.com/news/pixium-vision-complete-reverse-stock-split/2481842/Pixium Vision announced the completion of a reverse stock split, as decided by its Board of Directors on July 27, 2023, on the basis of 1 new share for 50 existing shares. Shareholders who could not hold a multiple of 50 existing shares will be automatically compensated of their fractio
- Bausch + Lomb’s ONE by ONE and Biotrue Eye Care Recycling Programs Recognized As Sustainability Service of the Year Award Winnerhttps://modernod.com/news/bausch-lombs-one-by-one-and-biotrue-eye-care-recycling-programs-recognized-as-sustainability-service-of-the-year-award-winner/2481839/Bausch + Lomb announced that its ONE by ONE and Biotrue Eye Care Recycling programs have been recognized as 2023 Sustainability Award winners by Business Intelligence Group in the “Sustainability Service of the Year” category. “Millions of people wear co
- Erin Powers Joins J&J Vision as Vice President of US Sales and Marketing for its Surgical Vision Portfoliohttps://modernod.com/news/erin-powers-joins-jj-vision-as-vice-president-of-us-sales-and-marketing-for-its-surgical-vision-portfolio/2481838/Johnson & Johnson announced the appointment of Erin Powers to the position of Vice President of US Sales and Marketing for its Surgical Vision portfolio. Ms. Powers will lead the US sales, marketing, and professional education teams, and will join the company within t
- SightGlass Vision Releases First White Paper on Diffusion Optics Technologyhttps://modernod.com/news/sightglass-vision-releases-first-white-paper-on-diffusion-optics-technology/2481837/SightGlass Vision announced the release of its
- Sight Sciences Appoints Matt Link as Chief Commercial Officerhttps://modernod.com/news/sight-sciences-appoints-matt-link-as-chief-commercial-officer/2481835/Sight Sciences announced the appointment of Matthew Link as its Chief Commercial Officer, effective September 11, 2023. Mr. Link has more than 20 years of experience building teams and leading innovation in the health care and medical technology industries, most recently serving as Mana
- Otsuka and ShapeTX Collaborate to Develop AAV Gene Therapies for Ocular Diseaseshttps://modernod.com/news/otsuka-and-shapetx-collaborate-to-develop-aav-gene-therapies-for-ocular-diseases/2481832/Otsuka Pharmaceutical and ShapeTX, a programmable medicine company using artificial intelligence (AI) and RNA to combat genetic diseases, announced a multitarget collaboration to develop intravitreally delivered adeno-associated viruses (AAVs) for ocular diseases, with options to add additional t
- Study Finds Role of Biosynthetic Fatty Acid Pathway Insufficiencies in Age-Related Macular Degenerationhttps://modernod.com/news/study-finds-role-of-biosynthetic-fatty-acid-pathway-insufficiencies-in-age-related-macular-degeneration/2481831/LSU Health Sciences Center announced the publication of findings that suggest that age-related macular degeneration (AMD) decreases an essential fatty acid, preventing the formation of a class of protective molecules and reducing repair potential. The research was led by Nicolas Bazan,
- NovaBay Pharmaceuticals’ Avenova Allograft is Launched in the United Stateshttps://modernod.com/news/novabay-pharmaceuticals-avenova-allograft-is-launched-in-the-united-states/2481830/NovaBay Pharmaceuticals announced the launch of the Avenova Allograft in the United States through its physician-dispensed channel. The company’s prescription optic allograft, which is intended for use as a protective covering during the repair of ocular surfaces, is manufactured using BioS
- NeoLight’s Icon Go With Fluorescein Angiography Capabilities Cleared by FDA for Portable Retinal Imaginghttps://modernod.com/news/neolights-icon-go-with-fluorescein-angiography-capabilities-cleared-by-fda-for-portable-retinal-imaging/2481829/NeoLight announced FDA Class II clearance for its Icon Go portable ophthalmic retinal imaging system with expanded fluorescein angiography (FA) capabilities. The Icon Go retinal diagnostics device is designed to provide retinal imaging across diverse patient care environments